Page 50 - Research Models News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Charles River Laboratories International (NYSE:CRL – Get Rating) had its price target lowered by Deutsche Bank Aktiengesellschaft from $260.00 to $250.00 in a research report released on Friday morning, The Fly reports. Several other brokerages also recently weighed in on CRL. Credit Suisse Group reduced their price objective on shares of Charles River Laboratories International […]

EverSource Wealth Advisors LLC lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 43.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,597 shares of the medical research company’s stock after selling 1,250 shares […]

In 2022, the US Animal Model Market size was valued at approximately US$ 947.3 million. From 2023 to 2033, demand for Animal Models in the United States is expected to rise at a 4.3% CAGR. The value of demand for Animal Models in the United States is expected to reach US$ 1,487.9 million by 2033. According to Future...

California Public Employees Retirement System cut its position in Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 1.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 111,975 shares of the medical research company’s stock after selling 1,578 shares during […]

Charles River Laboratories International (NYSE:CRL – Get Rating) had its price objective reduced by research analysts at Wells Fargo & Company from $290.00 to $280.00 in a note issued to investors on Friday, The Fly reports. Wells Fargo & Company‘s price target would indicate a potential upside of 43.04% from the company’s previous close. CRL […]